What is the management for acute otitis media (AOM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Otitis Media

High-dose amoxicillin (80-90 mg/kg/day divided into two doses) is the first-line antibiotic treatment for acute otitis media, combined with immediate pain management using acetaminophen or ibuprofen, though observation without antibiotics for 48-72 hours is appropriate for children ≥2 years with mild symptoms and reliable follow-up. 1, 2

Initial Assessment and Pain Management

  • Immediate pain control is mandatory regardless of whether antibiotics are prescribed, using oral acetaminophen or ibuprofen at age-appropriate doses during the first 24 hours when pain is most severe 1, 2
  • Proper diagnosis requires three elements: acute onset of symptoms, presence of middle ear effusion (confirmed by pneumatic otoscopy), and signs of middle ear inflammation such as bulging or distinctly erythematous tympanic membrane 1, 3

Decision: Immediate Antibiotics vs. Observation

Immediate Antibiotic Therapy Indicated For:

  • All children <2 years with bilateral AOM 1, 2
  • Any patient with otorrhea (perforated tympanic membrane) 1
  • Patients with severe symptoms: moderate to severe otalgia, otalgia ≥48 hours, or temperature ≥39°C/102.2°F 1, 4, 2
  • All adults with AOM 1

Observation Option (48-72 hours) Appropriate For:

  • Children ≥2 years with non-severe unilateral AOM and uncertain diagnosis 5, 1, 2
  • Otherwise healthy children with mild symptoms and reliable follow-up assured 1, 4
  • During observation, pain management must still be provided, and parents should be instructed to initiate antibiotics if symptoms worsen or fail to improve 5, 1

Antibiotic Selection

First-Line Therapy:

  • High-dose amoxicillin 80-90 mg/kg/day divided into two doses (not the older 40-45 mg/kg/day dosing) is recommended because it achieves adequate middle ear fluid concentrations against susceptible and intermediate-resistant Streptococcus pneumoniae 5, 1, 4, 2
  • This higher dosing is critical given increasing pneumococcal resistance and evidence that standard doses are inadequate 6, 7

Penicillin Allergy Alternatives:

  • Non-type I hypersensitivity (no anaphylaxis/urticaria): cefdinir, cefpodoxime, or cefuroxime 5, 1, 4, 2
  • Type I hypersensitivity (anaphylaxis/urticaria): azithromycin or clarithromycin, though macrolides have high pneumococcal resistance rates and should be used cautiously 4, 2, 8

Duration of Therapy:

  • 10 days for children <2 years and all patients with severe symptoms 5, 1
  • 7 days for children 2-5 years with mild to moderate AOM 5, 1
  • 5-7 days for children ≥6 years and adolescents 5, 1, 4

Treatment Failure Management

Reassessment at 48-72 Hours:

  • If symptoms worsen or fail to improve within 48-72 hours, reassess to confirm AOM diagnosis and exclude other causes 5, 1, 2
  • Note that slight worsening in the first 24 hours is normal and does not indicate treatment failure 5, 1
  • Expect improvement by 48-72 hours with fever decline, lessened irritability, and normalized sleeping/eating patterns 1

Second-Line Therapy:

  • Switch to amoxicillin-clavulanate (90 mg/kg/day based on amoxicillin component) if initial amoxicillin fails 5, 1, 2, 9
  • Alternative second-line options include ceftriaxone (intramuscular) or oral cefuroxime axetil 5, 9, 6
  • Do not use trimethoprim-sulfamethoxazole or erythromycin-sulfisoxazole due to substantial resistance 5

Persistent Treatment Failure:

  • Consider tympanocentesis for culture and susceptibility testing when multiple antibiotic courses have failed 5, 9, 6
  • Clindamycin (with or without coverage for H. influenzae and M. catarrhalis) may be used if tympanocentesis is unavailable 5
  • For multidrug-resistant S. pneumoniae serotype 19A, unconventional agents like levofloxacin or linezolid may be necessary after consultation with infectious disease specialists 5

Common Pitfalls and Important Considerations

Persistent Middle Ear Effusion (Not Treatment Failure):

  • 60-70% of children have middle ear effusion at 2 weeks post-treatment, 40% at 1 month, and 10-25% at 3 months—this is NOT an indication for continued or repeat antibiotics 5, 1
  • This represents otitis media with effusion (OME), which requires monitoring but not antibiotic therapy 5, 1
  • Only reassess if acute symptoms recur or never fully resolved 1

Antibiotic Completion:

  • Complete the full antibiotic course even if symptoms resolve early to ensure bacterial eradication and prevent treatment failure (21% failure rate with incomplete treatment vs. 5% with complete treatment) 1

Adverse Effects:

  • Amoxicillin-clavulanate causes diarrhea (20% vs. 4% with amoxicillin alone) and diaper dermatitis 5, 10
  • Azithromycin has lower gastrointestinal side effects (9% vs. 31% with amoxicillin-clavulanate) but higher resistance rates 8

Prevention Strategies

  • Ensure up-to-date pneumococcal conjugate vaccination 1, 4, 9
  • Consider annual influenza vaccination 1, 4
  • Reduce modifiable risk factors: encourage breastfeeding for ≥6 months, avoid supine bottle feeding, reduce pacifier use after 6 months, and consider altering daycare patterns for recurrent AOM 5, 1

References

Guideline

Acute Otitis Media Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Otitis media: diagnosis and treatment.

American family physician, 2013

Guideline

Acute Otitis Media Management in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.